Haemonetics News - HAE

Company Name	Stock Ticker Symbol	Market	Type
Haemonetics Corp	HAE	NYSE	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	0.00	0.00%	85.07	07:00:02

Open Price	Low Price	High Price	Close Price	Prev Close
				85.07

more quote information »

Recent News

Date	Time	Source	Heading
4/10/2024	16:58	PRNUS	Haemonetics Sets Date for Publishing Fourth Quarter and..
4/04/2024	06:30	PRNUS	Haemonetics Receives FDA Clearance for New TEG® 6s Global..
4/01/2024	08:00	PRNUS	Haemonetics Corporation Completes Acquisition of Attune..
3/05/2024	06:10	EDGAR2	Form 8-K - Current report
3/05/2024	06:00	PRNUS	Haemonetics Announces Definitive Agreement to Acquire Attune..
2/21/2024	17:57	PRNUS	Haemonetics to Present at Raymond James 45th Annual..
2/21/2024	17:55	PRNUS	Haemonetics to Present at Citi's 2024 Unplugged Medtech and..
2/13/2024	15:28	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2/09/2024	17:49	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2/08/2024	10:21	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2/08/2024	06:06	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2/08/2024	06:05	EDGAR2	Form 8-K - Current report
2/08/2024	06:00	PRNUS	Haemonetics 3rd Quarter Fiscal Year 2024 Earnings Release..
1/23/2024	16:13	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
1/11/2024	16:05	PRNUS	Haemonetics Sets Date for Publishing Third Quarter Fiscal..
12/12/2023	06:09	EDGAR2	Form 8-K - Current report
12/12/2023	06:00	PRNUS	Haemonetics Corporation Completes Acquisition of OpSens Inc.
12/07/2023	16:05	PRNUS	Haemonetics to Present at 42nd Annual J.P. Morgan Healthcare..
11/03/2023	16:36	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
11/02/2023	07:00	PRNCA	OPSENS OBTIENT UNE ORDONNANCE PROVISOIRE ET DÉPOSE UNE..
11/02/2023	06:19	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/02/2023	06:16	EDGAR2	Form 8-K - Current report
11/02/2023	06:00	PRNUS	Haemonetics 2nd Quarter Fiscal Year 2024 Earnings Release..
10/24/2023	16:27	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
10/24/2023	16:23	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
10/12/2023	06:10	EDGAR2	Form 8-K/A - Current report: [Amend]
10/10/2023	06:00	PRNCA	OPSENS SIGNS DEFINITIVE AGREEMENT FOR ITS ACQUISITION BY..
10/05/2023	16:05	PRNUS	Haemonetics Sets Date for Publishing Second Quarter Fiscal..
9/18/2023	16:16	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
9/13/2023	16:20	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
9/13/2023	16:19	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
9/12/2023	12:19	EDGAR2	Form 144 - Report of proposed sale of securities
9/11/2023	13:22	EDGAR2	Form 144 - Report of proposed sale of securities
9/07/2023	16:23	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
9/05/2023	14:23	EDGAR2	Form 144 - Report of proposed sale of securities
8/29/2023	06:30	PRNUS	Haemonetics Announces European Expansion for VASCADE®..
8/11/2023	16:10	EDGAR2	Form S-8 - Securities to be offered to employees in employee..
8/08/2023	16:45	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/08/2023	16:41	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/08/2023	16:38	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/08/2023	16:36	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/08/2023	16:34	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/08/2023	16:32	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/08/2023	16:29	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/08/2023	16:27	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/08/2023	06:09	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/08/2023	06:01	EDGAR2	Form 8-K - Current report
8/08/2023	06:00	PRNUS	Haemonetics 1st Quarter Fiscal Year 2024 Earnings Release..
8/07/2023	16:19	EDGAR2	Form 8-K - Current report
8/07/2023	16:10	PRNUS	Diane M. Bryant Joins Haemonetics' Board of Directors